/AEGIR.ST
AEGIR.ST Stock - AegirBio AB (publ)
Healthcare|Medical - Instruments & SuppliesSTO
$0.43+3.88%
+$0.02 (+3.88%) • Jul 8
36
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.10
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.47
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AEGIR.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.42 – $0.43
TARGET (TP)$0.49
STOP LOSS$0.39
RISK/REWARD1:1.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.75
52W High$1.80
52W Low$0.39
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $92,000 | $1.71M | $13.28M | N/A | N/A |
| Gross Profit | $44,000 | $-23,706,000 | $5.51M | N/A | N/A |
| Gross Margin | 47.8% | -1389.6% | 41.5% | N/A | N/A |
| Operating Income | $-56,158,000 | $-89,792,000 | $-81,516,000 | $-10,347,000 | N/A |
| Net Income | $-59,696,000 | $-362,830,000 | $-92,329,000 | $-10,347,000 | $-248 |
| Net Margin | -64887.0% | -21267.9% | -695.1% | N/A | N/A |
| EPS | $-2.38 | $-18.90 | $-5.64 | $-0.89 | $-0.00 |
Company Overview
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AEGIR.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.38
Q3 2024
EPS Surprise History
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Sep 30, 2024 | — | $-0.38 | — | — |
Q3 2024 | Aug 23, 2024 | — | $-0.26 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.42 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.16 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.69 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.67 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.69 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-14.94 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.64 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.99 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.75 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-2.89 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-1.73 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.88 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.93 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.18 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.22 | — | — |
Q3 2020 | Aug 27, 2020 | — | $-0.18 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.42 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AEGIR.ST
What is AEGIR.ST's current stock price?
AegirBio AB (publ) (AEGIR.ST) is currently trading at $0.43 per share. The stock has moved +3.88% today.
What is the analyst price target for AEGIR.ST?
No analyst price targets are currently available for this stock.
What sector is AegirBio AB (publ) in?
AegirBio AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.
What is AEGIR.ST's market cap?
AegirBio AB (publ) has a market capitalization of $0.02 billion, making it a small-cap company.
Does AEGIR.ST pay dividends?
No, AegirBio AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMNI.ST
Amniotics AB (publ)
$0.01
Mkt Cap: $0.0B
BIOS.ST
Bioservo Technologies AB (publ)
$0.02
Mkt Cap: $0.0B
CYXO.ST
Cyxone AB (publ)
$0.02
Mkt Cap: $0.0B
DIABIO.ST
Diagonal Bio AB (publ)
$0.01
Mkt Cap: $0.0B
IDOGEN.ST
Idogen AB (publ)
$0.12
Mkt Cap: $0.0B
L2S.ST
Learning 2 Sleep L2S AB (publ)
$0.02
Mkt Cap: $0.0B
PHARM.ST
Pharmiva AB (publ)
$0.56
Mkt Cap: $0.0B
PHLOG-B.ST
Pharmacolog i Uppsala AB (publ)
$0.10
Mkt Cap: $0.0B
VSDB.ST
VibroSense Dynamics AB
$0.75
Mkt Cap: $0.0B
ZICC.ST
Ziccum AB (publ)
$0.25
Mkt Cap: $0.0B
Explore stocks similar to AEGIR.ST for comparison